The ICMJE principles essentially say that journal editors should refuse to publish articles on new drugs unless the underlying clinical trial data are on deposit in an OA database independent of the drug manufacturer.
Posted by
Peter Suber at 9/08/2006 01:21:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.